Detalhe da pesquisa
1.
An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML.
Blood
; 141(3): 295-308, 2023 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36260765
2.
Activating STING1-dependent immune signaling in TP53 mutant and wild-type acute myeloid leukemia.
Proc Natl Acad Sci U S A
; 119(27): e2123227119, 2022 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35759659
3.
Ponatinib vs Imatinib in Frontline Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
JAMA
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38722621
4.
Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial.
Cancer
; 129(15): 2308-2320, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37078412
5.
KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results.
Blood
; 138(1): 11-22, 2021 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33827116
6.
Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia.
Blood
; 138(5): 387-400, 2021 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34351368
7.
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study.
Lancet
; 398(10299): 491-502, 2021 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34097852
8.
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
N Engl J Med
; 381(18): 1728-1740, 2019 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31665578
9.
Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemia.
J Oncol Pharm Pract
; 28(6): 1340-1349, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34134554
10.
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS).
Cancer
; 127(23): 4421-4431, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34424530
11.
Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study.
Br J Haematol
; 192(5): 832-842, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33529373
12.
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea.
Blood
; 134(18): 1498-1509, 2019 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31515250
13.
A Prospective Study of Peritransplant Sorafenib for Patients with FLT3-ITD Acute Myeloid Leukemia Undergoing Allogeneic Transplantation.
Biol Blood Marrow Transplant
; 26(2): 300-306, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31550496
14.
Peripheral blood blast rate of clearance is an independent predictor of clinical response and outcomes in acute myeloid leukaemia.
Br J Haematol
; 188(6): 881-887, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31804722
15.
Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: results from an international collaborative study.
Haematologica
; 105(1): 161-169, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31004014
16.
Favorable outcomes of acute leukemias of ambiguous lineage treated with hyperCVAD: a multi-center retrospective study.
Ann Hematol
; 99(9): 2119-2124, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32676733
17.
Optimizing pegylated asparaginase use: An institutional guideline for dosing, monitoring, and management.
J Oncol Pharm Pract
; 26(1): 74-92, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30917738
18.
Macrophage activation syndrome after granulocyte colony-stimulating factor in a patient with systemic lupus erythematosus.
Br J Haematol
; 204(3): 747-748, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38135898
19.
Decreased Bleeding Incidence with Direct Oral Anticoagulants Compared to Vitamin K Antagonist and Low-Molecular-Weight Heparin in Patients with Sickle Cell Disease and Venous Thromboembolism.
Acta Haematol
; 142(4): 233-238, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31108496
20.
Relapsed Philadelphia Chromosome-Positive Pre-B-ALL after CD19-Directed CAR-T Cell Therapy Successfully Treated with Combination of Blinatumomab and Ponatinib.
Acta Haematol
; 141(2): 107-110, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30695783